Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
NCT04925934
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
214
Enrollment
INDUSTRY
Sponsor class
Conditions
Lupus Erythematosus, Systemic
Interventions
DRUG:
VIB7734
OTHER:
Placebo
Sponsor
Amgen